Brain Cancer

The Food and Drug Administration accepted an Investigational New Drug application for MB-109, a novel agent that combines two mechanisms to treat recurrent glioblastoma and high-grade astrocytroma.

The brain cancer vaccine SurVaxM is among the novel treatments currently being studied for patients with glioblastoma.

As Len Goodman’s cause of death was announced and LSU defenseman Greg Brooks announces rare form of brain cancer, here is what’s happening in the oncology space this week.

The BRAF inhibitor AMB-1310 is currently being studied in both the United States and China for the treatment of patients with glioblastoma who are carrying the BRAF V600E mutation.

As Connor McGregor honors a fan who dies from cancer and Steve Scalise reveals information about his blood cancer, this is what’s happening in the oncology space this week.

Ashton’s story starts with her. Our beautiful, big-hearted, kind girl.

When both a patient and their loved one acting as their caregiver are facing cancer, “there has to be proper care for both,” one expert tells CURE®.

Phase 3 findings showed that vorasidenib improved progression-free survival and time to next treatment in patients with IDH-mutant glioma.

As wide receiver John Metchie returns to the field after cancer experience, and coach Brent Venables announces wife’s cancer diagnosis, this is what’s happening in the oncology space this week.

A patient with glioblastoma, a type of brain cancer, was dosed with a novel combination immunotherapy as part of a phase 2b trial.

Vorasidenib reduced the risk of disease progression or death for certain patients with low-grade brain cancer, recent study results showed.

Campaigns such as #BrewStacheStrong and Melesa’s Wings are uniting brewers and craft beer aficionados as they raise funds and awareness for cancer.

OKN-007 is being evaluated both alone and in combination with chemotherapy for patients with glioma or glioblastoma — both types of brain cancer.

From composer Ryuichi Sakamoto’s death to the “King of Chemo” cycling across the United States to raise funds for mental health and cancer charities, here’s what’s happening in the oncology space this week.

From Robin Roberts providing an update on her partner, Amber Laign’s “rough year” with breast cancer, to Kathy Griffin’s suspected cause of lung cancer, here’s what’s happening in the oncology space this week.

This approval is the first of its kind as a first-line systemic therapy for pediatric patients with low-grade gliomas of a specific mutation.

From a contestant on “Queer Eye” dying of cancer to a string of brain cancers in former Philadelphia Phillies players, here’s what’s happening in the oncology space this week.

Experts are concerned that the train derailment in Ohio may pose cancer risks down the line.

Patients who are financially struggling due to job loss after a cancer diagnosis may benefit from multidisciplinary back-to-work programs and financial counseling, according to an expert.

The treatment previously demonstrated significantly improved overall survival for patients with recurrent glioblastoma in a phase 1 study.

Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study findings showed.

From investigative journalist, Drew Griffin’s cancer-related death to Jane Fonda’s lymphoma update, here’s what’s happening in the oncology space this week.

Robert Atteberry never gave up, even after three cancer diagnoses, and has found a motivation and passion for competing in triathlons during survivorship.

From Toby Keith providing fans with an update since his stomach cancer diagnosis to Katie Couric donating $25,000 worth of baby formula to moms with breast cancer, here’s what’s happening in the cancer space this week.

The first patient was enrolled in a phase 1 trial analyzing MTX110 in patients with recurrent glioblastoma, an aggressive type of brain cancer.